title: [Symptomatic therapy of irritable bowel syndrome. Which drug for which symptoms?].
abstract: After establishing the diagnosis, reassuring the patient, and applying non-drug measures, pharmacotherapy forms a major pillar in the treatment of IBS, despite the fact that because the pathophysiology is still unknown, we have no causal drug treatment available. In the first instance, medication is a recommended supportive measure for application during the symptom-free intervals. It is oriented to the patient's leading complaints, and is directed towards the regulation of bowel movements, treatment of flatulency, and amelioration of painful motility disorders (e.g. spasms).
authors.affiliation: Abteilung für Gastroenterologie, Allgemeines Krankenhaus Celle, Siemensplatz 4, D-29223 Celle.
authors.forename: A
authors.initials: A
authors.lastname: Madisch
authors.forename: J
authors.initials: J
authors.lastname: Hotz
mesh_terms: D003109:Colonic Diseases, Functional / Q000188:drug therapy* / Q000209:etiology; D003131:Combined Modality Therapy; D004043:Dietary Fiber / Q000008:administration & dosage; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans
chemical_list: D004043:Dietary Fiber; D005765:Gastrointestinal Agents